Under the 340B program, drug manufacturers provide medicines at steep discounts, which providers are supposed to pass on to vulnerable patients.

Under the 340B program, drug manufacturers provide medicines at steep discounts, which providers are supposed to pass on to vulnerable patients.

Placing new limits on the 340B drug discount program would be a fresh challenge for hospitals as they confront funding cuts.